The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Trial Results Confirm Aspirin Prevents Primary Vascular Events in Patients With Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.
Read More
ARRIVE Trial: Daily Aspirin Did Not Lower First Heart Attack, Stroke Risk
August 27th 2018The benefits of taking aspirin to prevent a second or subsequent cardiovascular event have been well established in previous studies but the effectiveness of taking aspirin to prevent a first cardiovascular event has been unclear, despite 30 years of randomized clinical trials.
Read More
August 24 Pharmacy Week in Review: Contact Lens Hygiene, New Treatment for OCD
August 24th 2018This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Read More
Suboxone Use Increased in Medicaid-Expanding States
August 23rd 2018Buprenorphine with naloxone (Suboxone), an established treatment for opioid use disorder, has been increasingly used in states that chose to expand Medicaid eligibility under the Affordable Care Act, according to the results of a recent study.
Read More